跳至主要内容
临床试验/NCT06620744
NCT06620744已完成不适用

Magnetocardiography (MCG) Device Use in Patients With Elevated Troponin

SB Technology, Inc.2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年9月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
2
主要终点
Proportion (%) of all collected MCG data that meets the necessary data quality. requirements and are deemed suitable for analysis.

研究概览

简要总结

This prospective device study will examine the feasibility of MCG data collection in a hospital setting using the SandboxAQ MCG device as a potential method to more accurately and quickly quantify cardiac disease of patients with elevated Troponin.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Received a positive hs-cTnI based on the institutions laboratory normal value ranges (e.g. female ≥14 and male ≥35)

排除标准

  • Present STEMI
  • Having an active atrial fibrillation episode as seen on 12-lead ECG
  • Clear non-ischemic cause for symptoms (e.g. trauma)
  • Active thoracic metal implants

结局指标

主要结局

Proportion (%) of all collected MCG data that meets the necessary data quality. requirements and are deemed suitable for analysis.

时间窗: Per-scan, on average 5 minutes, day of enrollment

MCG Data Quality

次要结局

  • Sandbox MCG safety(30-days)

研究者

发起方
SB Technology, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Magnetocardiography (MCG) Device Use in Patients... | 临床试验